Title:
MARROW FIBERIZATION INHIBITOR
Document Type and Number:
Japanese Patent JP2017214291
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a novel medical drug that can suppress marrow fiberization associated with myelofibrosis.SOLUTION: As the present invention, there are exemplified, for example, (1) a medical drug for suppressing marrow fiberization associated with myelofibrosis which contains a compound having JAK2 inhibitory effect or a pharmaceutically acceptable salt thereof or solvate thereof, and a compound having MEK inhibitory effect or a pharmaceutically acceptable salt thereof or solvate thereof, and (2) a medical drug for suppressing marrow fiberization associated with myelofibrosis which contains a compound having JAK2 inhibitory effect or a pharmaceutically acceptable salt thereof or solvate thereof, and is used in combination with a medical drug containing a compound having MEK inhibitory effect or a pharmaceutically acceptable salt thereof or solvate thereof.SELECTED DRAWING: None
Inventors:
SHIMODA KAZUYA
HEI KOTARO
HEI KOTARO
Application Number:
JP2014208115A
Publication Date:
December 07, 2017
Filing Date:
October 09, 2014
Export Citation:
Assignee:
UNIV MIYAZAKI
NIPPON SHINYAKU CO LTD
NIPPON SHINYAKU CO LTD
International Classes:
A61K45/06; A61K31/166; A61K31/497; A61P7/00; A61P43/00; C07C259/10
Attorney, Agent or Firm:
Koji Masui
Previous Patent: Aromatic-carboxylic-acid amide compound
Next Patent: A weed killer containing a Aryl sulfonamide series compound or them
Next Patent: A weed killer containing a Aryl sulfonamide series compound or them